InvestorsHub Logo
Followers 229
Posts 21458
Boards Moderated 2
Alias Born 08/03/2006

Re: None

Monday, 02/01/2016 8:11:40 AM

Monday, February 01, 2016 8:11:40 AM

Post# of 15766
Mast Therapeutics Announces Positive Top-Line Results From Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Conducted At Mayo Clinic

Study met its primary endpoint; AIR001 was generally well-tolerated, with no treatment-related serious adverse events

http://finance.yahoo.com/news/mast-therapeutics-announces-positive-top-123000827.html

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.